Clinical Characteristics, Patterns of Use, and incidence of Adverse Events in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants in Colombia.
Manuel Enrique Machado-DuqueAndrés Gaviria-MendozaJuan Manuel Reyes-SanchezAlejandro MesaGamboa N CastañoLuis Fernando Valladales-RestrepoJorge Enrique Machado-AlbaPublished in: Vascular health and risk management (2023)
The patients with NVAF in this study were mainly older adults with multiple comorbidities. Compared to warfarin, DOACs were found to be equally effective, but safer and had a lower probability of discontinuation or switch.